首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >HOW DOES HEALTH TECHNOLOGY ASSESSMENT OF PERSONALIZED MEDICINE FOR NON-SMALL CELL LUNG CANCER DIFFER IN FRANCE, GERMANY, AND ENGLAND?

【24h】

HOW DOES HEALTH TECHNOLOGY ASSESSMENT OF PERSONALIZED MEDICINE FOR NON-SMALL CELL LUNG CANCER DIFFER IN FRANCE, GERMANY, AND ENGLAND?

机译：在法国，德国和英国，非小细胞肺癌个体化医疗的健康技术评估如何？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Sherwood A.; Mitrofan L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. HOW DOES HEALTH TECHNOLOGY ASSESSMENT OF PERSONALIZED MEDICINE FOR NON-SMALL CELL LUNG CANCER DIFFER IN FRANCE, GERMANY, AND ENGLAND? [J] . Sherwood A., Mitrofan L. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：在法国，德国和英国，非小细胞肺癌个体化医疗的健康技术评估如何？
2. Getting patients with non-small cell lung cancer on personalised treatment; the experience of Stratified Medicine Programme 2 (SMP2)/National Lung Matrix Trial (NLMT) in North East England [J] . Mariappan L., Gault A., Hogarth L., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2018,第Suppla1期

机译：将患有非小细胞肺癌的个性化治疗; 英格兰东北地区分层医学计划2（SMP2）/国家肺矩阵试验（NLMT）的经验
3. Getting patients with non-small cell lung cancer on personalised treatment; the experience of Stratified Medicine Programme 2 (SMP2)/National Lung Matrix Trial (NLMT) in North East England [J] . Mariappan L., Gault A., Hogarth L., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2018,第Suppla1期

机译：将患有非小细胞肺癌的个性化治疗; 英格兰东北地区分层医学计划2（SMP2）/国家肺矩阵试验（NLMT）的经验
4. A Sensitive Label-free Quantitation Approach for Personalized Phosphoproteomics Profiling of Non-small Cell Lung Cancer Tissues [C] . Yi-Ting Wang, Chia-Feng Tsai, Pei-Yi Lin, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：无小细胞肺癌组织的个性化磷蛋白组学分析的无敏感的定量定量方法
5. Exploring Efficacy of an Anti-Malarial Nanomedicine in Non-Small Cell Lung Cancer Treatment [D] . Parvathaneni, Vineela. 2021

机译：探讨抗疟疾纳米医生在非小细胞肺癌治疗中的疗效
6. Companies’ Health Technology Assessment Strategies and Practices in Australia Canada England France Germany Italy and Spain: An Industry Metrics Study [O] . Ting Wang, Neil McAuslane, Lawrence Liberti, 2020

机译：澳大利亚加拿大英格兰法国德国意大利和西班牙的公司健康技术评估策略和实践：一个行业指标研究
7. PHP132 Personalized Health Care in France, Germany and the United Kingdom: Are Health Technology Assessment Agencies Ready? [O] . Walzer S., Gartemann J., Zoellner Y.F., 2013

机译：法国，德国和英国的PHP132个性化医疗保健：医疗技术评估机构已经准备好了吗？

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号